<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00617435</url>
  </required_header>
  <id_info>
    <org_study_id>2006-A00397-44</org_study_id>
    <secondary_id>AU679</secondary_id>
    <secondary_id>2006-0132</secondary_id>
    <nct_id>NCT00617435</nct_id>
  </id_info>
  <brief_title>Impact of Trans Fatty Acids From Natural and Industrial Origin in the Induction of Insulin Resistance Development</brief_title>
  <acronym>Trans-Insulin</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Recherche Agronomique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Recherche Agronomique</source>
  <brief_summary>
    <textblock>
      The investigators' project has as for principal objective to understand the impact of trans&#xD;
      fatty acids from dairy products and industrial origin on the development of insulin&#xD;
      resistance in obese woman. Because of the different isomeric position of the double bound&#xD;
      those trans fatty acids may have different metabolic effects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women will be included in the study according to their susceptibility to develop a insulin&#xD;
      resistance (evaluated starting from the body index of mass IMC superior to 28 kg.m-², of the&#xD;
      waist measurement 88 cm). Once included in the study, the volunteers will receive for 4 weeks&#xD;
      butter, dairy products and biscuits enriched in stearic, elaidic or vaccenic acid. The&#xD;
      volunteers will undergo a measurement of the body composition by biphotonic absorptiometry as&#xD;
      well as a complete metabolic assessment (blood and urinary samples, clamp to insulin and&#xD;
      biopsies).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure of insulin sensitivity by an hyperinsulinemic- euglycemic clamp.</measure>
    <time_frame>before and after 4 weeks of diets.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle and adipose tissue biopsies and Body composition</measure>
    <time_frame>before and after 4 weeks of diet</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Insulin Resistance</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>V</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>N</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>J</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vaccenic acid enriched diet</intervention_name>
    <description>The experimental milk fat, entitled &quot;vaccenic acid enriched milk fat&quot; (VAMF), has been obtained by feeding cows with a diet containing sunflower oil.</description>
    <arm_group_label>V</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Elaidic acid enriched diet</intervention_name>
    <description>Mixture of vegetable oils (including partially hydrogenated oils)</description>
    <arm_group_label>N</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>control diet</intervention_name>
    <description>Mixed of different oil</description>
    <arm_group_label>J</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  female&#xD;
&#xD;
          -  waist measurement &gt; 88 cm&#xD;
&#xD;
          -  body mass index&gt; 28kg/m2&#xD;
&#xD;
          -  Affiliated to National Health Insurance&#xD;
&#xD;
          -  Subject giving his/her written informed consent&#xD;
&#xD;
          -  Subject willing to comply with the study procedures&#xD;
&#xD;
          -  Subject considered as normal after clinical examination and medical questionnaire&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Reported food allergies&#xD;
&#xD;
          -  Currently participating or having participated in another clinical trial during the&#xD;
             last 4 weeks prior to the beginning of this study&#xD;
&#xD;
          -  Hepatic or renal impairments&#xD;
&#xD;
          -  Positive serologies to HIV or HCV, determined on blood sample&#xD;
&#xD;
          -  pregnant or presently attempting to get pregnant or menopause or lactating Blood&#xD;
             donation done less than 2 months before the start of the study&#xD;
&#xD;
          -  Chronic pathologies: diabetes, hypertriglyceridemia, hypertension, cardiovascular&#xD;
             diseases, chronic inflammatory diseases&#xD;
&#xD;
          -  Intestine, cardiovascular, kidney and cancer pathologies in the last 5 years&#xD;
&#xD;
          -  Previous heavy intestine surgery (except appendicectomy)&#xD;
&#xD;
          -  Previous medical and/or surgery judged by the investigator as incompatible with this&#xD;
             study&#xD;
&#xD;
          -  High variation (&gt; 5%) of body weight during the last 3 months&#xD;
&#xD;
          -  Consuming nutritional supplements which could interfered with lipid metabolism (fish&#xD;
             oil capsule, vitamins, soja lecithins,…)&#xD;
&#xD;
          -  Heavy consumer of alcohol&#xD;
&#xD;
          -  Smoker or ex-smoker who stopped smoking less than 1 month before V0 (more than 5&#xD;
             cigarettes/dy).&#xD;
&#xD;
          -  Practising intensive physical exercise (&gt; 5 h per week)&#xD;
&#xD;
          -  Vegetarian or vegan&#xD;
&#xD;
          -  Being under someone's supervision&#xD;
&#xD;
          -  Refusal to be registered on the National Volunteers Data file&#xD;
&#xD;
          -  Disliking butter, margarine, cheese, biscuits and/or vegetable oil&#xD;
&#xD;
          -  Dietary habits unreliable to controlled food intake&#xD;
&#xD;
          -  Being in exclusion on the National Volunteers Data file&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yves Boirie, MD, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMR1019 INRA - Université Clermont1</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre de Recherche en Nutrition Humaine Auvergne</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de Recherche en Nutrition Humaine Rhônes-Alpes</name>
      <address>
        <city>Lyon</city>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Chardigny JM, Malpuech-Brugère C, Dionisi F, Bauman DE, German B, Mensink RP, Combe N, Chaumont P, Barbano DM, Enjalbert F, Bezelgues JB, Cristiani I, Moulin J, Boirie Y, Golay PA, Giuffrida F, Sébédio JL, Destaillats F. Rationale and design of the TRANSFACT project phase I: a study to assess the effect of the two different dietary sources of trans fatty acids on cardiovascular risk factors in humans. Contemp Clin Trials. 2006 Aug;27(4):364-73. Epub 2006 Apr 24.</citation>
    <PMID>16632411</PMID>
  </reference>
  <verification_date>March 2009</verification_date>
  <study_first_submitted>February 5, 2008</study_first_submitted>
  <study_first_submitted_qc>February 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2008</study_first_posted>
  <last_update_submitted>March 13, 2009</last_update_submitted>
  <last_update_submitted_qc>March 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2009</last_update_posted>
  <responsible_party>
    <name_title>Yves Boirie, MD, PU-PH</name_title>
    <organization>UMR1019 INRA - Université Clermont1</organization>
  </responsible_party>
  <keyword>Trans fatty acid</keyword>
  <keyword>Insulin resistance</keyword>
  <keyword>Skeletal muscle</keyword>
  <keyword>Adipose tissue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

